Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1966 1
1967 4
1968 1
1969 3
1970 2
1971 2
1972 3
1973 2
1974 1
1975 2
1981 2
1982 3
1983 5
1984 1
1985 7
1986 7
1987 10
1988 8
1989 10
1990 9
1991 8
1992 8
1993 9
1994 7
1995 7
1996 8
1997 10
1998 7
1999 4
2000 13
2001 9
2002 11
2003 14
2004 8
2005 6
2006 7
2007 7
2008 11
2009 8
2010 12
2011 11
2012 9
2013 11
2014 5
2015 6
2016 6
2017 8
2018 10
2019 12
2020 14
2021 11
2022 15
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Results by year

Filters applied: . Clear all
Page 1
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.
Jo T, Yoshihara S, Okuyama Y, Fujii K, Henzan T, Kahata K, Yamazaki R, Takeda W, Umezawa Y, Fukushima K, Ashida T, Yamada-Fujiwara M, Hanajiri R, Yonetani N, Tada Y, Shimura Y, Nishikii H, Shiba N, Mimura N, Ando J, Sato T, Nakashima Y, Ikemoto J, Iwaki K, Fujiwara SI, Ri M, Nagamura-Inoue T, Tanosaki R, Arai Y. Jo T, et al. Among authors: ashida t. Br J Haematol. 2023 Jul;202(2):256-266. doi: 10.1111/bjh.18831. Epub 2023 Apr 25. Br J Haematol. 2023. PMID: 37096915 Free article.
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group. Matsuoka K, et al. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):648-657. doi: 10.1016/S2468-1253(22)00022-X. Epub 2022 Mar 30. Lancet Gastroenterol Hepatol. 2022. PMID: 35366419 Clinical Trial.
[The ABCs of transfusion for hematologists].
Ashida T. Ashida T. Rinsho Ketsueki. 2018;59(10):2343-2348. doi: 10.11406/rinketsu.59.2343. Rinsho Ketsueki. 2018. PMID: 30305544 Review. Japanese.
Tumour-immune microenvironment in duodenal-type follicular lymphoma.
Inoue H, Rai S, Tanaka H, Espinoza JL, Watatani Y, Kumode T, Serizawa K, Nakayama S, Taniguchi Y, Morita Y, Tatsumi Y, Ashida T, Matsumura I. Inoue H, et al. Among authors: ashida t. Br J Haematol. 2020 Oct;191(2):243-252. doi: 10.1111/bjh.16715. Epub 2020 May 8. Br J Haematol. 2020. PMID: 32383789 Free article.
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
Rai S, Inoue H, Sakai K, Hanamoto H, Matsuda M, Maeda Y, Haeno T, Watatani Y, Kumode T, Serizawa K, Taniguchi Y, Hirase C, Espinoza JL, Morita Y, Tanaka H, Ashida T, Tatsumi Y, Nishio K, Matsumura I. Rai S, et al. Among authors: ashida t. Cancer Sci. 2022 Feb;113(2):660-673. doi: 10.1111/cas.15224. Epub 2021 Dec 5. Cancer Sci. 2022. PMID: 34837284 Free PMC article.
Effectiveness and Persistency of Ustekinumab Treatment for Ulcerative Colitis: A Phoenix retrospective Cohort Study.
Ando K, Fujiya M, Ueno N, Ito T, Maemoto A, Nasuno M, Tanaka H, Sakurai K, Katsurada T, Orii F, Ashida T, Motoya S, Kazama T, Yokoyama Y, Hirayama D, Nakase H. Ando K, et al. Among authors: ashida t. Crohns Colitis 360. 2024 Apr 13;6(2):otae024. doi: 10.1093/crocol/otae024. eCollection 2024 Apr. Crohns Colitis 360. 2024. PMID: 38711858 Free PMC article.
Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
Ikeda K, Minakawa K, Yamahara K, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Yamazaki R, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Ohto H, Ueda K, Tanosaki R. Ikeda K, et al. Among authors: ashida t. Transfusion. 2022 Jun;62(6):1280-1288. doi: 10.1111/trf.16877. Epub 2022 Apr 9. Transfusion. 2022. PMID: 35396716
366 results